[TLX] QoQ Quarter Result on 30-Jun-2021 [#Q2]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
29-Jun-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- -22.30%
YoY- -77.66%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/06/22 31/12/21 30/06/21 31/12/20 30/06/20 31/12/19 CAGR
Revenue 136,049 24,047 4,686 2,910 3,606 1,607 1,667 333.18%
PBT -27,919 -70,703 -61,993 -37,046 -35,157 -25,096 -25,690 2.80%
Tax 5,269 188 -13,997 -4,532 -8,571 -6,795 -8,192 -
NP -33,188 -70,891 -47,996 -32,514 -26,586 -18,301 -17,497 23.76%
Tax Rate - - - - - - - -
Total Cost 169,237 94,938 52,682 35,424 30,192 19,908 19,165 106.55%
Ratio Analysis
31/12/22 30/06/22 31/12/21 30/06/21 31/12/20 30/06/20 31/12/19 CAGR
NP Margin -24.39 -294.80 -1,024.24 -1,117.32 -737.27 -1,138.83 -1,049.33 -71.42%
Per Share
31/12/22 30/06/22 31/12/21 30/06/21 31/12/20 30/06/20 31/12/19 CAGR
EPS -0.10 -0.23 -0.17 -0.12 -0.10 -0.07 -0.07 12.61%
EPS Diluted -0.10 -0.23 -0.17 -0.12 -0.10 -0.07 -0.07 12.61%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.